TSRX..Biotech firm Trius Therapeutics, Inc. (NASDAQ:TSRX) has been mentioned by several media sources as being a possible target for acquisition. http://seekingalpha.com/article/1120381-the-momentum-of-trius-therapeutics?source=yahoo